Package 24338-270-01

Brand: vivimusta

Generic: bendamustine hydrochloride
NDC Package

Package Facts

Identity

Package NDC 24338-270-01
Digits Only 2433827001
Product NDC 24338-270
Product ID 24338-270_24f87fb8-dc5d-4daf-8afc-047afe1bcfee
Description

1 VIAL, MULTI-DOSE in 1 CARTON (24338-270-01) / 4 mL in 1 VIAL, MULTI-DOSE

Marketing

Marketing Status
Marketed Since 2025-04-01
Brand vivimusta
Generic bendamustine hydrochloride
Sample Package No

Linked Drug Pages (1)

VIVIMUSTA ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "24f87fb8-dc5d-4daf-8afc-047afe1bcfee", "openfda": {"unii": ["981Y8SX18M"], "rxcui": ["1726097", "2622914"], "spl_set_id": ["4df6548f-c4ad-4eb2-a54f-19766a3d90ca"], "manufacturer_name": ["Azurity Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, MULTI-DOSE in 1 CARTON (24338-270-01)  / 4 mL in 1 VIAL, MULTI-DOSE", "package_ndc": "24338-270-01", "marketing_start_date": "20250401"}], "brand_name": "VIVIMUSTA", "product_id": "24338-270_24f87fb8-dc5d-4daf-8afc-047afe1bcfee", "dosage_form": "INJECTION", "pharm_class": ["Alkylating Activity [MoA]", "Alkylating Drug [EPC]"], "product_ndc": "24338-270", "generic_name": "BENDAMUSTINE HYDROCHLORIDE", "labeler_name": "Azurity Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "VIVIMUSTA", "active_ingredients": [{"name": "BENDAMUSTINE HYDROCHLORIDE", "strength": "25 mg/mL"}], "application_number": "NDA212209", "marketing_category": "NDA", "marketing_start_date": "20250401", "listing_expiration_date": "20261231"}